Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 28, 2003

 

Date of Filing: October 28, 2003

 

 

Seattle Genetics, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-32405   91-1874389

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

21823 30th Drive SE

Bothell, Washington 98021

(Address of principal executive offices, including zip code)

 

(425) 527-4000

(Registrant’s telephone number, including area code)

 

Item 7.   Financial Statements and Exhibits

 

(c) Exhibits

 

99.1

    Press Release of Seattle Genetics, Inc. dated October 28, 2003.

 

Item 12.   Results of Operations and Financial Conditions

 

On October 28, 2003, Seattle Genetics, Inc. issued a press release announcing financial results for the quarter ended September 30, 2003 and providing an update on the SGN-15 clinical development program. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Form 8-K by reference.

 

The information in this Form 8-K, including the attached Exhibit, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

       

SEATTLE GENETICS, INC.

(Registrant)

Date: October 28, 2003

       By:  

/s/    Clay B. Siegall

           

Clay B. Siegall

President and Chief Executive Officer

INDEX TO EXHIBITS

 

Exhibit No.
   

Description

99.1    Press Release of Seattle Genetics, Inc. dated October 28, 2003.